Genetics Policy Institute

Home \| About \| World Stem Cell Summit \| Publications \| Stem Cell Action \| Education \| Awards \| News \| Donate \| Contact

BIOtech Now’s Tracy Krughoff talks to Bernard Siegel regarding the new NIH Stem Cell Guidelines
Hear the Podcast

NIH Draft Guidelines - Louis M. Guenin Comment letter

Lou Guenin
Louis M. Guenin, J.D.
Harvard Medical School Lecturer on Ethics in Science Dept. of Microbiology and Molecular Genetics

GPI is pleased to post a copy of the comments on the NIH Draft Guidelines submitted to the National Institutes of Health by Louis M. Guenin, author of The Morality of Embryo Use.

Bringing Stem Cell Science to the Classroom

Never before has a biology related topic dominated the 24-hour news cycle the way stem cells do. Stem cells are the ultimate teaching resource, creating wonderful opportunities and challenges for thousands of teachers. From development to disease, breakthrough technologies unlock what it means to be human, and students are intrigued and engaged like never before. However, the field of stem cell science constantly outpaces textbook publishers and classroom resources, leaving teachers behind. This is the first ever Stem Cell Educational Summit for teachers and produced in conjunction with the annual NABT meeting.
Learn More at StemCellEducationSummit.org.

GPI is the catalyst of the
“Pro-Cures Movement”

GPI was formed in 2003 with the mission of promoting and defending stem cell research and its application in medicine to develop therapeutics and cures for many otherwise intractable diseases and disorders.

GPI seeks to catalyze and help lead a global network of influential stakeholder groups representing patient advocates, scientists, physicians and health care professionals, industrialists, bioethicists, lawyers, educators, and policy-makers.

GPI pursues this mission through co-sponsorship and management of its flagship annual World Stem Cell Summit, publication of the World Stem Cell Report, special projects, speaking engagements, teaching initiatives, and strategic collaborations.

Upon this base of activities and relationships, GPI serves as a communications channel, helping to build the knowledge base needed for ethical and thoughtful policy-making in support of scientifically and medically worthy research and clinical translation in the broad field of stem cells and the even broader field of developmental biology. Learn More

GPI is exceptionally pleased to have been the subject of an Organizational Profile in the award-winning, Medline-indexed journal, Regenerative Medicine. Please read the article here.

GPI In the Spotlight

GPI Headlines
2010| 2009| 2008| 2007| 2006| 2005| 2004

GPI Appearances
2010| 2009| 2008| 2007| 2006| 2005| 2004

GPI Newsletters
Stay up to date on the latest stem cell news and developments with GPI newsletters. Subscribe Today!

Science the Way It Should Be
A Conversation With Curt Civin and Bernard Siegel on the State of Stem Cell Research

IASCR has compiled comments on the NIH Draft Guidelines for Human Stem Cell Research. "Advancing the Promise: Leading Research Institutions, Patients and Scholars Comment on the Draft NIH Guidelines for Human Stem Cell Research" is available in PDF format.

NIH Logo
NIH Draft Guidelines - GPI Comment Letter

GPI’s comments in this letter comprise the following ten points:

I. Significance of Human Stem Cell Research

II. Significance of the NIH Guidelines for Stem Cell Research

III. Five Part Framework for Comparing and Contrasting hSC Research Guidelines

IV. Need to Apply the NIH Stem Cell Research Guidelines as a Safe Harbor

V. Issues relating to the Types of Research Proposed as Ineligible for NIH Funding

VI. Issues of Drafting Precision, Interpretation, and Implementation

VII. NIH’s Leadership in Extending Stem Cell Research and Medicine

VIII. Addressing the Projected Growth of Stem Cell-related Clinical Trials

IX. Importance of Funding Studies of Ethical, Legal, and Social Implications in hSC Research

X. Periodic Review and Evolution of the Guidelines

Click here to read the entire letter.